微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 1.63% | -40.94% | 5.84% | 67/140 | 2.12% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | 1.54% | -54.03% | 741.67% | 55/140 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | -0.24% | -102.49% | -109.72% | 92/140 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 2.47% | -70.63% | -10.51% | 78/140 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 2.76% | -56.54% | -17.61% | 62/140 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 3.35% | -25.56% | -65.25% | 16/140 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 9.64% | 4.33% | 14.63% | 33/140 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 8.41% | -6.45% | 32.44% | 27/140 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 6.35% | -5.08% | 41.11% | 22/140 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 4.5% | -1.75% | -51.3% | 11/140 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 9.24% | -67.51% | 2.78% | 38/140 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 8.99% | -71.51% | 34.38% | 33/140 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 6.69% | -77.1% | 46.07% | 29/140 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 4.58% | -80.68% | -83.9% | 20/140 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | 28.44% | 59.24% | -9.86% | 15/140 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 31.55% | 55.8% | 7.97% | 14/140 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 29.22% | 78.61% | 23.29% | 11/140 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 23.7% | 346.33% | 32.7% | 8/140 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 17.86% | -23.68% | -11.8% | 45/140 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 20.25% | -11.38% | 23.78% | 26/140 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 16.36% | -10.36% | 208.1% | 20/140 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 5.31% | 23.49% | -77.31% | 32/140 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 23.4% | 30.8% | 2.41% | 44/140 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 22.85% | 61.26% | 25.21% | 22/140 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 18.25% | 92.71% | 324.42% | 24/140 | 15.17% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 4.3% | 16.85% | -75.96% | 20/140 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 17.89% | 6.36% | 26.25% | 46/140 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 14.17% | -13.01% | 49.63% | 16/140 | 10.54% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 9.47% | -14.14% | 157.34% | 16/140 | 6.76% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 3.68% | -29.37% | -78.12% | 15/140 | 2.73% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 16.82% | -12.44% | 3.25% | 44/140 | 14.23% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 16.29% | 0.74% | 47.69% | 7/140 | 9.71% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 11.03% | 12.78% | 111.71% | 5/140 | 4.54% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 5.21% | 30.58% | -72.88% | 7/140 | 2.78% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 19.21% | 20.51% | 18.8% | 28/140 | 14.51% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 16.17% | 8.67% | 65.34% | 8/140 | 9.49% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 9.78% | 2.19% | 145.11% | 12/140 | 6.11% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 3.99% | 9.02% | -74.97% | 8/140 | 2.74% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 15.94% | -20.02% | 7.12% | 33/140 | 16.44% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 14.88% | 44.05% | 55.49% | 7/140 | 8.86% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 9.57% | -10.39% | 161.48% | 12/140 | 6.35% | *ST明德 | 23.29% | 行业排名> |
| 2016-03-31 | 3.66% | -63.58% | -81.64% | 5/140 | 2.3% | 健帆生物 | 7.75% | 行业排名> |